Bate, M., Rushton, E. and Currie, D. A (1991). Cells with persistent twist expression are the embryonic precursors of adult muscles in Drosophila. Development 113, 79-89.[Abstract]
Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Francomano, C. A. and Muenke, M (1996). Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genet 14, 174-176.[Medline]
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. and Weintraub, H (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.[Medline]
Bianco, P., Fisher, L. W., Young, M. F., Termine, J. D. and Robey, P. G (1991). Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int 49, 421-426.[Medline]
Bourgeois, P., Bolcato-Bellemin, A. L., Danse, J. M., Bloch-Zupan, A., Yoshiba, K., Stoetzel, C. and Perrin-Schmitt, F (1998). The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum. Mol. Genet 7, 945-957.[Abstract/Free Full Text]
Canalis, E. and Raisz, L. G (1980). Effect of fibroblast growth factor on cultured fetal rat calvaria. Metabolism: Clinical & Experimental 29, 108-114.[Medline]
Carlton, M. B., Colledge, W. H. and Evans, M. J (1998). Crouzon-like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus. Dev. Dyn 212, 242-249.[Medline]
Chen, J. K., Shapiro, H. S., Wrana, J. L., Reimers, S., Heersche, J. N. and Sodek, J (1991). Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 11, 133-143.[Medline]
Chen, Z. F. and Behringer, R. R (1995). Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9, 686-699.[Abstract/Free Full Text]
Coffin, J. D., Florkiewicz, R. Z., Neumann, J., Mort-Hopkins, T., Dorn, G. W. 2nd, Lightfoot, P., German, R., Howles, P. N., Kier, A., O'Toole, B. A., et al (1995). Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell 6, 1861-1873.[Abstract]
Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G. and Ornitz, D. M (1996). Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet 12, 390-397.[Medline]
Debiais, F., Hott, M., Graulet, A. M. and Marie, P. J (1998). The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J. Bone Miner. Res 13, 645-654.[Medline]
Delezoide, A. L., Benoist-Lasselin, C., Legeai-Mallet, L., Le Merrer, M., Munnich, A., Vekemans, M. and Bonaventure, J (1998). Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech. Dev 77, 19-30.[Medline]
Deng, C. X., Wynshaw-Boris. A., Shen, M. M., Daugherty, C., Ornitz, D. M. and Leder, P (1994). Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 8, 3045-3057.[Abstract/Free Full Text]
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder P (1996). Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921.[Medline]
El Ghouzzi, V., Le Merrer, M., Perrin-Schmitt, F., Lajeunie, E., Benit, P., Renier, D., Bourgeois, P., Bolcato-Bellemin, A. L., Munnich, A. and Bonaventure, J (1997). Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nature Genet 15, 42-46.[Medline]
Fuchtbauer, E. M (1995). Expression of M-twist during postimplantation development of the mouse. Dev. Dyn 204, 316-322.[Medline]
Galvin, B. D., Hart, K. C., Meyer, A. N., Webster, M. K. and Donoghue, D. J (1996). Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc. Natl Acad. Sci. USA 93, 7894-7899.[Abstract/Free Full Text]
Hebrok, M., Wertz, K. and Fuchtbauer, E. M (1994). M-twist is an inhibitor of muscle differentiation. Dev. Biol 165, 537-544.[Medline]
Heinrichs, A. A., Banerjee, C., Bortell, R., Owen, T. A., Stein, J. L., Stein, G. S. and Lian, J. B (1993). Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation. J. Cell Biochem 53, 240-250.[Medline]
Hodgkinson, J. E., Davidson, C. L., Beresford, J. and Sharpe, P. T (1993). Expression of a human homeobox-containing gene is regulated by 1,25(OH)2D3 in bone cells. Biochim Biophys Acta 1174, 11-16.[Medline]
Hoffmann, H. M., Beumer, T. L., Rahman, S., McCabe, L. R., Banerjee, C., Aslam, F., Tiro, J. A., van Wijnen, A. J., Stein, J. L., Stein, G. S. and Lian, J. B (1996). Bone tissue-specific transcription of the osteocalcin gene: role of an activator osteoblast-specific complex and suppressor hox proteins that bind the OC box. J. Cell Biochem 61, 310-324.[Medline]
Howard, T. D., Paznekas, W. A., Green, E. D., Chiang, L. C., Ma, N., Ortiz de Luna, R. I., Garcia Delgado, C., Gonzalez-Ramos, M., Kline, A. D., Jabs, E. W (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet 15, 36-41.[Medline]
Iseki, S., Wilkie, A. O. M., Heath, J. K., Ishimaru, T., Eto, K. and Morriss-Kay, G (1997). Fgfr2 and Osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124, 3375-3384.[Abstract]
Jabs, E. W., Muller, U., Li, X., Ma, L., Luo, W., Haworth, I. S., Klisak, I., Sparkes, R., Warman, M. L., Mulliken, J. B., et al (1993). A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75, 443-450.[Medline]
Jabs, E. W., Li, X., Scott, A. F., Meyers, G., Chen, W., Eccles, M., Mao, J. I., Charnas, L. R., Jackson, C. E. and Jaye, M (1994). Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genet 8, 275-279.[Medline]
Jen, Y., Manova, K. and Benezra, R (1996). Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev. Dyn 207, 235-252.[Medline]
Karsenty, G (1998). Genetics of skeletogenesis. Dev. Genet 22, 301-313.[Medline]
Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A. and Suda, T (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol 127, 1755-1766.[Abstract/Free Full Text]
Kawaguchi, N., DeLuca, H. F. and Noda, M (1992). Id gene expression and its suppression by 1,25-dihydroxyvitamin D3 in rat osteoblastic osteosarcoma cells. Proc. Natl Acad. Sci. USA 89, 4569-4572.[Abstract/Free Full Text]
Kettunen, P., Karavanova, I. and Thesleff, I (1998). Responsiveness of developing dental tissues to fibroblast growth factor \320 expression of splicing alternatives of FGFR1,-2,-3, and FGFR4 \320 and stimulation of cell proliferation by FGF-2,-4,-8, and-9. Dev Gen 22, 374-385.[Medline]
Kim, H-J., Rice, D. P. C., Kettunen, P. J. and Thesleff, I (1998). FGF-, BMP-and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125, 1241-1251.[Abstract]
Liu, Y-H., Tang, Z., Kundu, R. K., Wu,L., Luo, W., Zhu, D., Sangiorgi, F., Snead, M. L. and Maxson, R. E (1999). Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 205, 260-274.[Medline]
Mackenzie, A., Ferguson, M. W. J. and Sharpe, P. T (1992). Expression patterns of the homeobox gene, Hox-8, in the mouse embryo suggest a role in specifying tooth initiation and shape. Development 115, 403-420.[Abstract]
Malaval, L., Liu, F., Roche, P. and Aubin, J. E (1999). Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J. Cell Biochem 74, 616-627.[Medline]
McMahon, A. P., Champion, J. E., McMahon, J. A. and Sukhatme, V. P (1990). Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissues. Development 108, 281-287.[Abstract]
Mangasarian, K., Li, Y., Mansukhani, A. and Basilico, C (1997). Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J. Cell Physiol 172, 117-125.[Medline]
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al (1994). A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 8, 269-273.[Medline]
Murray, S. S., Glackin, C. A., Winters, K. A., Gazit, D., Kahn, A. J. and Murray, E. J (1992). Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J. Bone Miner. Res 7, 1131-1138.[Medline]
Neilson, K. M. and Friesel, R. E (1995). Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem 270, 26037-26040.[Abstract/Free Full Text]
Ogata, T. and Noda, M (1991). Expression of Id, a negative regulator of helix-loop-helix DNA binding proteins, is down-regulated at confluence and enhanced by dexamethasone in a mouse osteoblastic cell line, MC3T3E1. Biochem. Biophys. Res. Com 180, 1194-1199.[Medline]
Ogata, T., Wozney, J M., Benezra, R. and Noda, M (1993). Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc. Natl Acad. Sci. USA 90, 9219-9222.[Abstract/Free Full Text]
Opperman, L.A., Chhabra, A., Nolen, A.A., Bao, Y., and Ogle, R.C (1998). Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J. Craniofac. Genet. Dev. Biol 18, 150-158.[Medline]
Opperman, L. A., Passarelli, R. W., Morgan, E. P. Reintjes, M. and Ogle, R. C (1995). Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J. Bone Miner. Res 10, 1979-1987.
Opperman, L.A., Sweeney, T.M., Redmon, J., Persing, J.A., and Ogle, R.C (1993). Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dyn 198, 312-322.[Medline]
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G. and Goldfarb, M. ( (1996). Receptor specificity of the fibroblast growth factor family. J. Biol. Chem 271, 15292-15297.[Abstract/Free Full Text]
Orr-Urtreger, A., Givol, D., Yayon, A., Yarden, Y. and Lonai, P (1991). Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113, 1419-1434.[Abstract]
Orr-Urtreger, A., Bedford, M. T., Burakova, T., Arman, E., Zimmer, Y., Yayon, A., Givol, D. and Lonai, P (1993). Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol 158, 475-486.[Medline]
Paznekas, W. A., Cunningham, M. L., Howard, T. D., Korf, B. R., Lipson, M. H., Grix, A. W., Feingold, M., Goldberg, R., Borochowitz, Z., Aleck, K., et al (1998). Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am. J. Hum. Genet 62, 1370-1380.[Medline]
Pesce, S. and Benezra, R (1993). The loop region of the helix-loop-helix protein Id1 is critical for its dominant negative activity. Molec. Cell. Biol 13, 7874-7880.[Abstract/Free Full Text]
Peters, K. G., Werner, S., Chen, G. and Williams, L. T (1992). Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114, 233-243.[Abstract]
Rice, D. P. C., Kim, H. J. and Thesleff, I (1997). Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. Bone 21, 479-486.[Medline]
Satokata, I. and Maas, R (1994). Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nature Genet 6, 348-356.[Medline]
Shishido, E., Higashijima, S., Emori, Y. and Saigo, K (1993). Two FGF-receptor homologues of Drosophila: one is expressed in mesodermal primordium in early embryos. Development 117, 751-761.[Abstract]
Tamura, M. and Noda, M (1994). Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors. J. Cell Biol 126, 773-782.[Abstract/Free Full Text]
Tamura, M. and Noda, M (1999). Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. J. Cell Biochem 72, 167-176.[Medline]
Vainio, S., Jalkanen, M., Vaahtokari, A., Sahlberg, C., Mali, M., Bernfield, M. and Thesleff, I (1991). Expression of syndecan gene is induced early, is transient, and correlates with changes in mesenchymal cell proliferation during tooth organogenesis. Dev. Biol 147, 322-333.[Medline]
Wilke, T. A., Gubbels, S., Schwartz, J. and Richman, J. M (1997). Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Dev. Dyn 210, 41-52.[Medline]
Wilkie, A. O. M (1997). Craniosynostosis: genes and mechanisms. Hum. Mol. Genet 6, 1647-1656.[Abstract/Free Full Text]
Wilkie, A. O., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P., et al (1995). Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet 9, 165-172.[Medline]
Xu, X., Weinstein, M., Li, C., Naski, M., Cohen, R. I., Ornitz, D. M., Leder, P. and Deng, C (1998). Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125, 753-765.[Abstract]
Yamaguchi, T. P., Harpal, K., Henkemeyer, M. and Rossant, J (1994). fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev 8, 3032-3044.[Abstract/Free Full Text]
